Notably, elevated intravascular XO causes vasculotoxicity in hemolytic anemia, and its inhibition by febuxostat—an XO inhibitor and anti‐gout drug—reduces hemolysis and vascular injury in SCD mice [62]. This evidence concerns the gene XDH and gout.